AMPK activation inhibits I f in female and male mouse pacemaker cells. (A–D) Whole-cell recordings of If in 3-mo-old female (A and B) and 3-mo-old male (C and D) mouse SAN cells in control (black) and after 4-h treatment with AMPK activator (AICAR 1 mM) (red). Data are obtained from N = 3 females and N = 3 males. (A and C) Representative current traces (left) and activation curves (right). Best fitting with the Boltzmann equation yielded the following values: (A) V1/2 = −91.0 ± 1.67; s = 8.2 ± 0.5 mV (n = 14) and V1/2 = −89.5 ± 1.69 mV; s = 7.5 ± 0.4 mV (n = 13) (n.s.); (C) V1/2 = −88.9 ± 1.76; s = 9.2 ± 0.5 mV (n = 12) and V1/2 = −88.2 ± 1.65 mV; s = 9.1 ± 0.7 mV (n = 15) (n.s.), for control and AICAR-treated cells, respectively. (B and D) Steady-state I/V relations; bar graphs on the left show the distributions of current densities at −125 mV. Predicted means ± SEM assuming GLMM (Gamma distribution) were (B) −35.4 ± 4.03 (n = 14) and −24.2 ± 2.87 pA/pF (n = 13) (P = 0.0982, n.s.); (D) −44.6 ± 5.49 (n = 12) and −25.2 ± 2.77 pA/pF (n = 15) (P = 0.0030, **) for control and AICAR-treated cells, respectively. The difference in current density in female vs. males did not reach significance (P = 0.05067). Significance P values were adjusted with Tukey’s test assuming four groups. Details of statistical analysis are shown in Table S1.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.